Core Viewpoint - Advanced Manufacturing Industry Investment Fund plans to reduce its stake in He Eye Hospital by up to 3,106,074 shares, accounting for 2% of the total share capital, due to personal funding needs [1] Financial Performance - In 2024, the company reported operating revenue of 1.096 billion yuan, a decrease of 7.56% year-on-year [2][3] - The net profit attributable to shareholders was -27.40 million yuan, down 143.11% year-on-year [2][3] - The net profit after deducting non-recurring gains and losses was -28.79 million yuan, a decline of 152.03% year-on-year [2][3] - The net cash flow from operating activities was 156 million yuan, down 11.95% year-on-year [2][3] - For Q1 2025, the company achieved operating revenue of 291 million yuan, an increase of 2.35% year-on-year [4] - The net profit attributable to shareholders for Q1 2025 was 32.53 million yuan, up 12.27% year-on-year [4] - The net cash flow from operating activities for Q1 2025 was 79.94 million yuan, an increase of 36.89% year-on-year [4] Shareholder Structure - He Eye Hospital's controlling shareholders are He Wei, He Xiangdong, and Fu Lifang, who are family members and have signed a concerted action agreement [2] Stock Issuance and Fundraising - The company raised a total of 1.296 billion yuan from its initial public offering, with a net amount of 1.164 billion yuan after deducting issuance costs [5] - The funds are allocated for various projects, including hospital expansions and information technology improvements [5] Dividend Distribution - In 2021, the company approved a cash dividend of 6 yuan per 10 shares, totaling approximately 72.94 million yuan, and a capital reserve conversion of 3 shares for every 10 shares held [6]